[go: up one dir, main page]

BRPI0906608A2 - Métodos e composições para o tratamento de hemorragia subaracnóide aneurismal coronária e arterial. - Google Patents

Métodos e composições para o tratamento de hemorragia subaracnóide aneurismal coronária e arterial.

Info

Publication number
BRPI0906608A2
BRPI0906608A2 BRPI0906608-0A BRPI0906608A BRPI0906608A2 BR PI0906608 A2 BRPI0906608 A2 BR PI0906608A2 BR PI0906608 A BRPI0906608 A BR PI0906608A BR PI0906608 A2 BRPI0906608 A2 BR PI0906608A2
Authority
BR
Brazil
Prior art keywords
coronary
compositions
treatment
methods
subarachnoid hemorrhage
Prior art date
Application number
BRPI0906608-0A
Other languages
English (en)
Inventor
Marshall L Summar
Frederick E Barr
Reid Carleton Thompson
Original Assignee
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt
Publication of BRPI0906608A2 publication Critical patent/BRPI0906608A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0906608-0A 2008-01-31 2009-02-02 Métodos e composições para o tratamento de hemorragia subaracnóide aneurismal coronária e arterial. BRPI0906608A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2517008P 2008-01-31 2008-01-31
PCT/US2009/032826 WO2009099999A2 (en) 2008-01-31 2009-02-02 Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage

Publications (1)

Publication Number Publication Date
BRPI0906608A2 true BRPI0906608A2 (pt) 2015-07-14

Family

ID=40932329

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0906608-0A BRPI0906608A2 (pt) 2008-01-31 2009-02-02 Métodos e composições para o tratamento de hemorragia subaracnóide aneurismal coronária e arterial.

Country Status (16)

Country Link
US (3) US20090197964A1 (pt)
EP (1) EP2240170B1 (pt)
JP (2) JP5623916B2 (pt)
KR (2) KR101932831B1 (pt)
CN (2) CN105106186A (pt)
AU (2) AU2009212693B2 (pt)
BR (1) BRPI0906608A2 (pt)
CA (1) CA2715260C (pt)
DK (1) DK2240170T3 (pt)
ES (1) ES2732810T3 (pt)
HU (1) HUE045571T2 (pt)
PL (1) PL2240170T3 (pt)
PT (1) PT2240170T (pt)
RU (1) RU2528097C2 (pt)
SG (1) SG196863A1 (pt)
WO (1) WO2009099999A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346382B1 (en) 1999-06-01 2002-02-12 Vanderbilt University Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto
US9486429B2 (en) * 1999-06-01 2016-11-08 Vanderbilt University Therapeutic methods employing nitric oxide precursors
CA2912259C (en) 2005-05-27 2020-04-28 Mark H. Schoenfisch Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
CN104083352A (zh) * 2008-01-31 2014-10-08 范德比尔特大学 对于肺部病症的治疗
SG196863A1 (en) 2008-01-31 2014-02-13 Univ Vanderbilt Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
EP4249001A3 (en) 2009-08-21 2023-11-29 Novan, Inc. Topical gels
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
ES2695173T3 (es) 2011-02-28 2019-01-02 Novan Inc Partículas de sílice modificadas con S-nitrosotiol que liberan óxido nítrico y procedimientos de fabricación de las mismas
AU2016286115B9 (en) 2015-06-29 2021-02-04 Vanderbilt University Intravenous administration of citrulline during surgery
WO2020247853A1 (en) 2019-06-05 2020-12-10 Asklepion Pharmaceuticals, Llc Improved method of synthesis and purification of citrulline

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA716628B (en) 1970-10-15 1972-06-28 Richardson Merrell Spa Composition and method for treatment of hepatic disease and mental fatigue
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4458066A (en) * 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
NL8102724A (nl) 1980-07-11 1982-02-01 Stamicarbon Werkwijze voor de bereiding van copolymeren van etheen met tenminste een ander 1-alkeen.
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4769331A (en) * 1981-09-16 1988-09-06 University Patents, Inc. Recombinant methods and materials
US4736866B1 (en) * 1984-06-22 1988-04-12 Transgenic non-human mammals
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US5573933A (en) * 1987-04-14 1996-11-12 Luminis Pty, Ltd. Transgenic pigs
US4996236A (en) * 1988-06-22 1991-02-26 Takeda Chemical Industries, Ltd. Therapeutic composition for hepatic encephalopathy
US5162215A (en) * 1988-09-22 1992-11-10 Amgen Inc. Method of gene transfer into chickens and other avian species
US5399346A (en) * 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5286634A (en) * 1989-09-28 1994-02-15 Stadler Joan K Synergistic method for host cell transformation
US5633076A (en) * 1989-12-01 1997-05-27 Pharming Bv Method of producing a transgenic bovine or transgenic bovine embryo
EP0441119A3 (en) * 1990-01-09 1992-10-14 Richard D. Levere The use of l-arginine in the treatment of hypertension and other vascular disorders
US5279833A (en) * 1990-04-04 1994-01-18 Yale University Liposomal transfection of nucleic acids into animal cells
US5614396A (en) * 1990-06-14 1997-03-25 Baylor College Of Medicine Methods for the genetic modification of endogenous genes in animal cells by homologous recombination
US5489742A (en) * 1990-10-23 1996-02-06 Board Of Regents, The University Of Texas System Transgenic rats and animal models of inflammatory disease
US5641484A (en) * 1990-12-04 1997-06-24 Board Of Regents, The University Of Texas System Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
AU651650B2 (en) * 1990-12-04 1994-07-28 Board Of Regents, The University Of Texas System Methods and compositions for the suppression of (NEU) mediated transformation
US5643567A (en) * 1990-12-04 1997-07-01 Board Of Regents, The University Of Texas System Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen
DK0560928T3 (da) * 1990-12-05 1997-12-01 Gen Hospital Corp Anordninger til behandling af pulmonal vasokonstriktion og astma
US5550316A (en) * 1991-01-02 1996-08-27 Fox Chase Cancer Center Transgenic animal model system for human cutaneous melanoma
US5550024A (en) * 1991-04-19 1996-08-27 Biotechnology Research & Development Corporation Genetic markers for pig litter size
US5374651A (en) 1991-09-27 1994-12-20 Board Of Regents, The University Of Texas System Methods and compositions for the treatment of hypotension with arginine free essential and essential amino acids and arginine derivatives
US5286739A (en) * 1991-09-27 1994-02-15 Board Of Regents, University Of Texas System Parenteral formulations for the inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
US5334380A (en) 1991-09-27 1994-08-02 Board Of Regents, The University Of Texas System Anti-endotoxin, interleukin-1 receptor antagonist and anti-tumor necrosis factor antibody with arginine-free formulations for the treatment of hypotension
US5385940A (en) 1992-11-05 1995-01-31 The General Hospital Corporation Treatment of stroke with nitric-oxide releasing compounds
WO1994016740A1 (en) 1993-01-29 1994-08-04 Brigham And Women's Hospital The use of nitric oxide-delivering compounds for the treatment or prevention of alcoholic liver injury
US5891459A (en) * 1993-06-11 1999-04-06 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
US5646008A (en) * 1993-06-22 1997-07-08 The Regent Of The University Of Michigan Vertebrate apoptosis gene: compositions and methods
US5625125A (en) * 1994-08-09 1997-04-29 Dnx Biotherapeutics Phospholipase A2 expressing transgenic animals
US5543430A (en) * 1994-10-05 1996-08-06 Kaesemeyer; W. H. Method and formulation of stimulating nitric oxide synthesis
US5648061A (en) * 1995-05-24 1997-07-15 Thomas Jefferson University In vivo and in vitro model of cutaneous photoaging
US6331543B1 (en) 1996-11-01 2001-12-18 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
US5874471A (en) 1997-02-27 1999-02-23 Waugh; William Howard Orthomolecular medical use of L-citrulline for vasoprotection, relaxative smooth muscle tone and cell protection
US6028107A (en) * 1997-02-27 2000-02-22 Waugh; William Howard Orthomolecular medical use of L-citrulline for vasoprotection, relaxative smooth muscle tone and cell protection
JP2001519386A (ja) * 1997-10-15 2001-10-23 トーマス・ジェファーソン・ユニバーシティ 哺乳動物における血管収縮または血管痙攣を予防または緩和するための一酸化窒素供与体組成物、方法、装置およびキット
US6796966B2 (en) 1997-10-15 2004-09-28 Jeffrey E. Thomas Apparatus, and kits for preventing of alleviating vasoconstriction or vasospasm in a mammal
US20010056068A1 (en) * 1998-03-04 2001-12-27 Kristof Chwalisz Method of treatment and prevention of nitric oxide deficiency-related disorders with citrulline and citrulline derivatives
US20020068365A1 (en) 1998-07-28 2002-06-06 Eric H. Kuhrts Controlled release nitric oxide producing agents
US9486429B2 (en) 1999-06-01 2016-11-08 Vanderbilt University Therapeutic methods employing nitric oxide precursors
US6346382B1 (en) 1999-06-01 2002-02-12 Vanderbilt University Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto
US6182295B1 (en) * 1999-06-14 2001-02-06 Kevin Sciglia Hat
JP3506114B2 (ja) 2000-01-25 2004-03-15 株式会社ニコン モニタ装置及びこのモニタ装置を具えた研磨装置及び研磨方法
RU2202269C2 (ru) * 2001-02-14 2003-04-20 Жильвинас Закарявичюс Способ прогнозирования исхода хирургического лечения у больных среднего возраста в остром периоде внутричерепных кровоизлияний аневризматической природы
US6689810B2 (en) * 2001-08-21 2004-02-10 Cellular Sciences, Inc. Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide
EP1448600A4 (en) * 2001-09-07 2004-12-22 Bristol Myers Squibb Co POLYNUCLEOTIDE ENCODING A NOVEL HUMAN G PROTEIN-RELATED RECEPTOR, HGPRMBY39
US20030134332A1 (en) * 2001-11-28 2003-07-17 Boykin Joseph V. Diagnosis of endothelial dysfunction by nitric oxide bioactivity index
US6899140B2 (en) 2002-08-12 2005-05-31 Wellstream International Limited Flexible pipe and method of manufacturing same using metal reinforced tape
ATE538814T1 (de) * 2005-01-06 2012-01-15 Discovery Lab Inc Dosierungsschema unter verwendung eines tensids zur behandlung oder verhinderung von lungendysplasien
CA2632238A1 (en) * 2005-12-01 2007-06-07 Nps Pharmaceuticals, Inc. A biomarker of improved intestinal function
SG196863A1 (en) 2008-01-31 2014-02-13 Univ Vanderbilt Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage
CN104083352A (zh) * 2008-01-31 2014-10-08 范德比尔特大学 对于肺部病症的治疗
US20090291066A1 (en) 2008-05-22 2009-11-26 Apostolos Pappas composition and method of treating facial skin defect

Also Published As

Publication number Publication date
KR20100135728A (ko) 2010-12-27
US20180360787A1 (en) 2018-12-20
US9943494B2 (en) 2018-04-17
EP2240170A4 (en) 2014-10-29
RU2528097C2 (ru) 2014-09-10
PT2240170T (pt) 2019-06-24
CA2715260C (en) 2017-07-04
CA2715260A1 (en) 2009-08-13
KR101932831B1 (ko) 2018-12-27
EP2240170A2 (en) 2010-10-20
JP6042392B2 (ja) 2016-12-14
AU2009212693A1 (en) 2009-08-13
CN102369006A (zh) 2012-03-07
KR20170005497A (ko) 2017-01-13
AU2014204508A1 (en) 2014-08-07
RU2010132580A (ru) 2012-03-10
JP2015017119A (ja) 2015-01-29
SG196863A1 (en) 2014-02-13
ES2732810T3 (es) 2019-11-26
DK2240170T3 (da) 2019-07-15
AU2009212693B2 (en) 2014-05-01
JP5623916B2 (ja) 2014-11-12
US20120088835A1 (en) 2012-04-12
JP2011519821A (ja) 2011-07-14
EP2240170B1 (en) 2019-05-22
HUE045571T2 (hu) 2020-01-28
WO2009099999A2 (en) 2009-08-13
US20090197964A1 (en) 2009-08-06
CN105106186A (zh) 2015-12-02
US10500181B2 (en) 2019-12-10
AU2014204508B2 (en) 2016-07-14
WO2009099999A3 (en) 2013-11-28
PL2240170T3 (pl) 2019-11-29

Similar Documents

Publication Publication Date Title
BRPI0906608A2 (pt) Métodos e composições para o tratamento de hemorragia subaracnóide aneurismal coronária e arterial.
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
PT2367561E (pt) Composições e métodos para o tratamento da doença celíaca
EP3685783C0 (en) ENDOLUMINAL LASER ABLATION DEVICE FOR VEIN TREATMENT
BRPI0911612A2 (pt) composições e métodos para o tratamento da esclerose múltipla.
BRPI0911923A2 (pt) dispositivos filamentosos para o tratamento de defeitos vasculares
PT2240137T (pt) Aparelho para o tratamento da obesidade
ATE550329T1 (de) Heterobicyclische sulfonamidderivate zur behandlung von diabetes
EP2296563A4 (en) MINIMALLY INVASIVE SURGICAL TOOL
BRPI0921321A2 (pt) métodos para o tratamento de indwcções e tumores
LT2478907T (lt) Kompozicijos vėžiui gydyti
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
EP1773224A4 (en) Endovascular cryotreatment catheter
EP2313146A4 (en) DEVICES FOR TREATING VASCULAR ANEVRYSM
PL3354276T3 (pl) Kompozycje do leczenia zapalenia przewodu pokarmowego
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
PT2894165T (pt) Métodos e composições para o tratamento de distúrbios associados ao complemento
EP2281065A4 (en) METHOD OF EVALUATION AND COMPARISON OF IMMUNO-DIRECTORIES
SMP200900085B (it) 3-imidazolil-indoli per il trattamento di malattieproliferative.
EP2034844A4 (en) METHOD OF TREATING IRRITABLE COLON SYNDROME WITH PREDOMINANT DIARRHEA
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
BRPI0817870A2 (pt) dispositivo para tratamento de aneurisma
DK2279501T3 (da) Fremgangsmåde og system til styring af produktionen af genstande
DK2056842T3 (da) Modificeret galactosylceramid til behandling af cancerøse sygdomme
IT1391866B1 (it) Composizione iniettabile di polinucleotidi per il trattamento di patologie osteoarticolari.

Legal Events

Date Code Title Description
B08E Application fees: payment of additional fee required [chapter 8.5 patent gazette]

Free format text: COMPLEMENTAR A RETRIBUICAO DA 5A ANUIDADE, DE ACORDO COM TABELA VIGENTE, REFERENTE A GUIA DE RECOLHIMENTO 92130093633-8.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE (COMPLEMENTACAO).

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]
B08G Application fees: restoration [chapter 8.7 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL